2 results
Approved WMOCompleted
To evaluate the effect of real-life food consumption on the pharmacokinetics of nilotinib in CML patients
Approved WMORecruiting
Primary Objectives• To describe the anti-tumor activity and toxicity of commercially available, targeted anti-cancer drugs used for treatment of patients with an advanced solid tumor, multiple myeloma or non-Hodgkin lymphoma that harbours a genomic…